Vanguard Group Inc

13F Holdings History for aTYR PHARMA INC - COMMON STOCK (ATYR)

Symbol: ATYR on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 4.66M shares
Security Ownership: 5.23%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in aTYR PHARMA INC COMMON STOCK (ATYR)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.66M shares of aTYR PHARMA INC COMMON STOCK (ATYR). This represents 5.23% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	5.23%		$15.1M	4.66M			$3.24	13G	6/30/2025	29 Jul 2025 11:24:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$23.6M	4.66M	+648,313	+16.2%	$5.07	Q2 2025
3/31/2025	0%	+0%	$12.1M	4.01M	+401,808		$3.02	Q1 2025
12/31/2024	0%	+0%	$13M	3.6M	+617,349	+20.7%	$3.62	Q4 2024
9/30/2024	0%	+0%	$5.26M	2.99M	+335,421	+12.6%	$1.76	Q3 2024
6/30/2024	0%		$4.14M	2.65M			$1.56	Q2 2024
3/31/2024	0%	+0%	$5.17M	2.65M	+283,703	+12%	$1.95	Q1 2024
12/31/2023	0%	+0%	$3.34M	2.37M	+84,848	+3.72%	$1.41	Q4 2023
9/30/2023	0%	0%	$3.61M	2.28M	-17,108	-0.74%	$1.58	Q3 2023
6/30/2023	0%	+0%	$4.97M	2.3M	+206,457	+9.86%	$2.16	Q2 2023
3/31/2023	0%	+0%	$4.4M	2.09M	+954,131	+83.7%	$2.10	Q1 2023
12/31/2022	0%		$2.5M	1.14M	+593	+0.05%	$2.19	Q4 2022
9/30/2022	0%		$3.42M	1.14M			$3.00	Q3 2022
6/30/2022	0%		$3.23M	1.14M			$2.83	Q2 2022
3/31/2022	0%	+0%	$6.1M	1.14M	+26,342	+2.37%	$5.35	Q1 2022
12/31/2021	0%	+0%	$8.32M	1.11M	+206,450	+22.8%	$7.47	Q4 2021
9/30/2021	0%	+0%	$8.23M	907K	+311,539	+52.3%	$9.08	Q3 2021
6/30/2021	0%	+0%	$2.9M	595K	+300,097	+102%	$4.88	Q2 2021
3/31/2021	0%	+0%	$1.31M	295K	+44,958	+18%	$4.45	Q1 2021
12/31/2020	0%	+0%	$971K	250K	+16,297	+6.97%	$3.88	Q4 2020
9/30/2020	0%	+0%	$755K	234K	+11,912	+5.37%	$3.23	Q3 2020
6/30/2020	0%		$985K	222K			$4.44	Q2 2020
3/31/2020	0%	+0%	$621K	222K	+56,355	+34%	$2.80	Q1 2020
12/31/2019	0%		$690K	166K	-900	-0.54%	$4.17	Q4 2019
9/30/2019	0%	+0%	$583K	166K	+166,483	NEW	$3.50	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.